ImmunoCellular Therapeutics
| Region | Nordamerika |
| ISIN | US4525362046 |
| Sektor | Biotechnologie |
| Website | http://www.imuc.com/ |
ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.
| Titel | Datum |
|---|---|
| Bumi Armada, MISC, Zetrix, Heitech Padu, Kelington, Kim Hin, Hibiscus, Johor Plantations Group, Ajiya, Pekat, Kimlun, Jiankun & Farm Price | vor ungefähr einem Monat |
| MISC, Bumi Armada call off merger proposal | vor ungefähr einem Monat |
| DNV awards GASA approval to joint LCO2 carrier design by MOL, MISC, PETRONAS CCS Ventures and SDARI | vor ungefähr 2 Monaten |
| MOL, MISC and PETRONAS form joint venture to advance cross-border CO2 transportation | vor ungefähr 3 Monaten |
| Petronas, MISC and MOL debut LCO2 carrier JV | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Idea Fabrik (3 Artikel) | |
| Iconic Minerals (2 Artikel) | |
| Incyte (1 Artikel) | |
| India Globalization Capital (2 Artikel) | |
| Alle anzeigen | |